Modulation of Intestinal and Pulmonary Inflammation by Lactobacillus Diet Supplementation in Pediatric Cystic Fibrosis (MoHuM-1)
Modulation of Intestinal and Pulmonary Inflammation by Lactobacillus Rhamnosus Diet Supplementation in Pediatric Cystic Fibrosis (MoHuM-1)
Sponsor: Cantonal Hospital of St. Gallen
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Cantonal Hospital of St. Gallen
Other Cystic Fibrosis trials with similar outcome
Listed as NCT01837355, this NA trial focuses on Cystic Fibrosis and Microbiota and remains terminated or withdrawn. Sponsored by Cantonal Hospital of St. Gallen, it has been updated 11 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Jul 2025 — Sep 2025 [monthly]
Terminated NA
Status: Unknown → Terminated
-
Sep 2024 — Jul 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jul 2023 — Jul 2024 [monthly]
Unknown Status NA
▶ Show 6 earlier versions
-
Jan 2021 — Jul 2023 [monthly]
Unknown Status NA
-
May 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — May 2020 [monthly]
Recruiting NA
-
May 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Feb 2018 — May 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2017 — Feb 2018 [monthly]
Recruiting NA
First recorded
Feb 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cantonal Hospital of St. Gallen
- Insel Gruppe AG, University Hospital Bern
- Swiss Federal Institute of Technology
For direct contact, visit the study record on ClinicalTrials.gov .